Pregnancy Loss Signal from Prostaglandin Eye Drop Use in Pregnancy: A Disproportionality Analysis Using Japanese and US Spontaneous Reporting Databases-Reference-Cited by-同舟云学术

Pregnancy Loss Signal from Prostaglandin Eye Drop Use in Pregnancy: A Disproportionality Analysis Using Japanese and US Spontaneous Reporting Databases

Published:2021-11-19 Issue: Volume: Page:
ISSN:2199-1154
Container-title:Drugs - Real World Outcomes
language:en
Short-container-title:Drugs - Real World Outcomes

Author:

Sakai Takamasa^ORCID,Mori Chiyo,Koshiba Honoka,Yuminaga Ryuta,Tanabe Kouichi,Ohtsu Fumiko

Funder

japan society for the promotion of science

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40801-021-00287-y.pdf

Reference23 articles.

1. Kant A, de Vries L, Rolfes L. Surveillance of drug safety during pregnancy: insight in current international activities, future intentions and need for support of national Pharmacovigilance Centres. Drug Saf. 2019;42(1):35–43.

2. van De Ven NS, Pozniak AL, Levi JA, Clayden P, Garratt A, Redd C, et al. Analysis of pharmacovigilance databases for dolutegravir safety in pregnancy. Clin Infect Dis. 2020;70(12):2599–606.

3. Sakai T, Ohtsu F, Mori C, Tanabe K, Goto N. Signal of miscarriage with aripiprazole: a disproportionality analysis of the Japanese Adverse Drug Event Report database. Drug Saf. 2017;40(11):1141–6.

4. Deepak P, Stobaugh DJ. Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease. Aliment Pharmacol Ther. 2014;40(9):1035–43.

5. Sessa M, Mascolo A, Callréus T, Capuano A, Rossi F, Andersen M. Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®. Sci Rep. 2019;9(1):7236.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A disproportionality analysis of low molecular weight heparin in the overall population and in pregnancy women using the FDA adverse event reporting system (FAERS) database;Frontiers in Pharmacology;2024-08-12

2. From Eye Care to Hair Growth: Bimatoprost;Pharmaceuticals;2024-04-27

3. Pregnancy outcomes in the medical management of glaucoma: An international multicenter descriptive survey;European Journal of Ophthalmology;2023-09-06

4. Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System;Frontiers in Pharmacology;2022-11-10

5. Doxycycline use and adverse pregnancy or neonatal outcomes: A descriptive study using the United States Food and Drug Administration Adverse Event Reporting System database;Health Science Reports;2022-11